scispace - formally typeset
M

M. Ortí-Pareja

Researcher at University of Alcalá

Publications -  50
Citations -  2371

M. Ortí-Pareja is an academic researcher from University of Alcalá. The author has contributed to research in topics: Parkinson's disease & Levodopa. The author has an hindex of 29, co-authored 50 publications receiving 2226 citations.

Papers
More filters
Journal ArticleDOI

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

TL;DR: The gambling behavior appears more often in the “on” periods of motor fluctuations and it begins after the onset of Parkinson's disease in most patients and worsens with levodopa therapy suggest that it could be related to the dopaminergic tone in patients with Parkinson’s disease and motor fluctuations.
Journal ArticleDOI

Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs

TL;DR: When compared with controls, PD patients showed higher jitter, lower H/N ratio, lower frequency and intensity variability of the sentence, and lower phonational range and reported a higher frequency of the presence of low voice-intensity, monopitch, voice arrests, and struggle, which seem to be unaffected by the duration and severity of the disease.
Journal ArticleDOI

Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease.

TL;DR: The possibility that low CSF zinc levels were due to a deficiency of dietary intake seems unlikely, but it is possible that they might be related to the interaction of beta-amyloid and/or amyloid precursor protein with zinc, that could result in a depletion of zinc levels.
Journal ArticleDOI

Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease

TL;DR: It is suggested that low CSF zinc concentrations might be related with the risk for Parkinson's disease, although they could berelated with oxidative stress processes.
Journal ArticleDOI

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.

TL;DR: The results suggest that low CSF and serum vitamin E concentrations in AD patients could be related with a deficiency of dietary intake of vitamin E.